TCM
LABU icon

Tradewinds Capital Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Tradewinds Capital Management’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26
Closed -$4K – 468
2022
Q2 		$4K Buy
+26
New +$4.43K ﹤0.01% 289
2019
Q3 		– Sell
-2
Closed -$2K – 629
2019
Q2 		$2K Hold
2
– – ﹤0.01% 532
2019
Q1 		$3K Sell
2
-1
-33% -$1.04K ﹤0.01% 505
2018
Q4 		$2K Buy
+3
New +$3.15K ﹤0.01% 555

Other funds holding LABU

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

Tradewinds Capital Management's LABU Position: Q3 2022 in Review

Tradewinds Capital Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2022, closing a stake of 26 shares — an estimated $4K sold.

Tradewinds Capital Management first reported a position in LABU in Q4 2018 and held it in 4 quarters. The position peaked at $4K in Q2 2022. 47 funds tracked by Wall St. Rank hold LABU as of Q3 2022.

  • Tradewinds Capital Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2022 after selling out during the quarter.
  • Tradewinds Capital Management sold 26 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2022, an estimated $4K.
  • Tradewinds Capital Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2018 and held it in 4 quarters.
  • Tradewinds Capital Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $4K in Q2 2022.
  • 47 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2022.

Based on Tradewinds Capital Management's 13F filing for Q3 2022, filed 18 Oct 2022.